THRX-195518

THRX-195518 is the major metabolite of Revefenacin (HY-15851), a lung-selective and long-acting muscarinic antagonist. THRX-195518 can be utilized in research related to chronic obstructive pulmonary disease[1].

Product Specifications

CAS Number

[909800-36-8]

UNSPSC

12352005

Target

Drug Metabolite

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Others

Smiles

O=C(OC1CCN(CCN(C(C2=CC=C(CN3CCC(C(O)=O)CC3)C=C2)=O)C)CC1)NC4=C(C5=CC=CC=C5)C=CC=C4

Molecular Formula

C35H42N4O5

Molecular Weight

598.73

References & Citations

[1]Lo A, et al. Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease. Clin Pharmacokinet. 2021 Mar;60 (3) :391-401.